MUFG Securities EMEA’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $7.22M | Buy |
9,517
+391
| +4% | +$295K | 0.08% | 165 |
|
|
2026
Q2 | $5.69M | Sell |
9,126
-8,006
| -47% | -$5.45M | 0.06% | 196 |
|
|
2026
Q1 | $13.2M | Buy |
17,132
+13,000
| +315% | +$10M | 0.2% | 86 |
|
|
2025
Q4 | $3.19M | Buy |
4,132
+2,182
| +112% | +$1.48M | 0.04% | 241 |
|
|
2025
Q3 | $1.1M | Buy |
1,950
+1,643
| +535% | +$929K | 0.03% | 236 |
|
|
2025
Q2 | $161K | Buy |
+307
| New | +$171K | 0.01% | 238 |
|
|
2022
Q4 | – | Sell |
-135
| Closed | -$93K | – | 175 |
|
|
2022
Q3 | $93K | Hold |
135
| – | – | ﹤0.01% | 123 |
|
|
2022
Q2 | $80K | Hold |
135
| – | – | ﹤0.01% | 108 |
|
|
2022
Q1 | $94K | Hold |
135
| – | – | ﹤0.01% | 127 |
|
|
2021
Q4 | $85K | Hold |
135
| – | – | ﹤0.01% | 169 |
|
|
2021
Q3 | $82K | Sell |
135
-645
| -83% | -$400K | ﹤0.01% | 270 |
|
|
2021
Q2 | $436K | Sell |
780
-2,100
| -73% | -$1.06M | ﹤0.01% | 265 |
|
|
2021
Q1 | $1.36M | Buy |
2,880
+1,700
| +144% | +$828K | 0.01% | 289 |
|
|
2020
Q4 | $570K | Buy |
1,180
+559
| +90% | +$302K | ﹤0.01% | 338 |
|
|
2020
Q3 | $348K | Buy |
+621
| New | +$377K | ﹤0.01% | 351 |
|
|
2020
Q2 | – | Sell |
-1,280
| Closed | -$625K | – | 492 |
|
|
2020
Q1 | $625K | Sell |
1,280
-1,600
| -56% | -$660K | 0.01% | 354 |
|
|
2019
Q4 | $1.08M | Buy |
2,880
+2,004
| +229% | +$674K | 0.01% | 428 |
|
|
2019
Q3 | $243K | Sell |
876
-59,792
| -99% | -$17.7M | ﹤0.01% | 314 |
|
|
2019
Q2 | $19M | Buy |
60,668
+57,872
| +2,070% | +$19.3M | 0.2% | 86 |
|
|
2019
Q1 | $1.15M | Sell |
2,796
-2,690
| -49% | -$1.11M | 0.01% | 380 |
|
|
2018
Q4 | $2.05M | Sell |
5,486
-5,266
| -49% | -$1.93M | 0.02% | 251 |
|
|
2018
Q3 | $4.34M | Buy |
10,752
+1,721
| +19% | +$655K | 0.06% | 171 |
|
|
2018
Q2 | $3.12M | Buy |
9,031
+152
| +2% | +$47.5K | 0.06% | 173 |
|
|
2018
Q1 | $3.06M | Sell |
8,879
-43,739
| -83% | -$15.2M | 0.06% | 147 |
|
|
2017
Q4 | $19.8M | Buy |
52,618
+49,070
| +1,383% | +$19.9M | 0.46% | 51 |
|
|
2017
Q3 | $1.59M | Buy |
3,548
+1,625
| +85% | +$773K | 0.06% | 87 |
|
|
2017
Q2 | $944K | Sell |
1,923
-3,716
| -66% | -$1.63M | 0.04% | 63 |
|
|
2017
Q1 | $2.18M | Buy |
5,639
+3,802
| +207% | +$1.41M | 0.11% | 30 |
|
|
2016
Q4 | $674K | Buy |
1,837
+764
| +71% | +$291K | 0.06% | 25 |
|
|
2016
Q3 | $431K | Buy |
+1,073
| New | +$430K | 0.39% | 26 |
|
Other funds holding REGN
MUFG Securities EMEA's REGN Position: Q3 2026 in Review
MUFG Securities EMEA increased its Regeneron Pharmaceuticals (REGN) stake by 4.3% in Q3 2026, buying an estimated $295K and bringing the position to 9,517 shares worth $7.22M. The position accounts for 0.08% of the portfolio, ranked #165.
MUFG Securities EMEA first reported a position in REGN in Q3 2016 and has held it in 30 quarters since. The position peaked at $19.8M in Q4 2017. 1,274 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- MUFG Securities EMEA held 9,517 shares of Regeneron Pharmaceuticals worth $7.22M as of Q3 2026.
- MUFG Securities EMEA bought 391 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $295K.
- Regeneron Pharmaceuticals made up 0.08% of MUFG Securities EMEA's portfolio in Q3 2026, its #165 holding.
- MUFG Securities EMEA first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 30 quarters since.
- MUFG Securities EMEA's Regeneron Pharmaceuticals position peaked at $19.8M in Q4 2017.
- 1,274 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on MUFG Securities EMEA's 13F filing for Q3 2026, filed 12 Nov 2026.